1h Free Analyst Time
The digital pathology market is forecast to grow by USD 1.12 billion during 2023-2028, accelerating at a CAGR of 16.98% during the forecast period. The report on the digital pathology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing adoption of IoT infrastructure among laboratories, increasing demand for high productivity and reduced turnaround time among end-users, and significant adoption of digital pathology in education and training.
The digital pathology market is segmented as below:
By Product
- Digital slide scanner
- Software
By Application
- Hospitals and laboratories
- Independent and small clinics
- Research centers
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the digital pathology market covers the following areas:
- Digital pathology market sizing
- Digital pathology market forecast
- Digital pathology market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global digital pathology market: 3DHISTECH Ltd., Apollo Enterprise Imaging Corp., Co Diagnostics Inc., Corista, Danaher Corp., F. Hoffmann La Roche Ltd., General Electric Co., Hamamatsu Photonics KK, Huron Digital Pathology, Indica Labs Inc., Inspirata Inc., Kanteron Systems SLU, Koninklijke Philips N.V., Mikroscan Technologies Inc., Objective Pathology Services, Olympus Corp., Proscia Inc., Sectra AB, Visiopharm AS, and XIFIN Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is integration of AI into digital pathology systems."
According to the report, one of the major drivers for this market is the growing adoption of IoT infrastructure among laboratories.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3DHISTECH Ltd.
- Apollo Enterprise Imaging Corp.
- Co Diagnostics Inc.
- Corista
- Danaher Corp.
- F. Hoffmann La Roche Ltd.
- General Electric Co.
- Hamamatsu Photonics KK
- Huron Digital Pathology
- Indica Labs Inc.
- Inspirata Inc.
- Kanteron Systems SLU
- Koninklijke Philips N.V.
- Mikroscan Technologies Inc.
- Objective Pathology Services
- Olympus Corp.
- Proscia Inc.
- Sectra AB
- Visiopharm AS
- XIFIN Inc.
